about
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cellsAryl hydrocarbon receptor control of a disease tolerance defence pathwayForced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetesCpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis.Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes.Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation.IDO mediates TLR9-driven protection from experimental autoimmune diabetes.Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12.Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapyImmunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymesA GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune SuppressionReverse signaling through GITR ligand enables dexamethasone to activate IDO in allergyIL-23 neutralization protects mice from Gram-negative endotoxic shockTryptophan catabolism generates autoimmune-preventive regulatory T cellsPositive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammationAdvances in indoleamine 2,3-dioxygenase 1 medicinal chemistry
P50
Q28588016-5A0D07E2-4B46-4BE3-B412-8F72B9E0A5F6Q33901562-9F53E16C-6435-4D0D-BF7D-2A2931E13A79Q34323684-F370CD14-F36D-45A5-B722-7176604E9FBFQ37710236-1AF1BC37-FFF3-48DC-A678-8D11F90A4115Q38871609-4AA3D7E7-0AAC-4FB7-AF47-552AA9EBD452Q42958588-749F5089-1120-4A80-A623-265EA8ED1D25Q43258639-8462C793-4B11-4957-87DE-C2BCF2E16180Q43782014-7F0E804E-FAF7-449A-B345-7862D996FB18Q45092706-672A1FD0-67C8-4BAA-9795-AC24F96F55F1Q45163458-83041084-F338-42CF-B961-20D8AC9FE61AQ46737044-230473A0-0F93-432B-A03D-2B925F474C68Q56897532-98811387-AEA4-463D-98EE-1EDF4B85118FQ56901234-80C9DFC5-6F00-4CB8-B1FA-4D026B7BEB4EQ58855369-0A35987F-1AF0-4876-9E60-C63F30E5CE44Q58855390-4469403C-7AE1-4768-ACB8-59A99CE6D1F7Q60494040-1BAD47EE-BE2C-421F-AD8A-873E22E0119FQ60494045-5B440399-0051-4E48-B93B-BC9BA7599B17Q89555118-BE6F9A4A-C392-4EF3-937D-ACF892ECF907Q90950060-9E97BD01-7737-4607-88C8-006A1370EC70
P50
description
researcher ORCID ID = 0000-0002-3967-7954
@en
wetenschapper
@nl
name
Claudia Volpi
@ast
Claudia Volpi
@en
Claudia Volpi
@es
Claudia Volpi
@nl
type
label
Claudia Volpi
@ast
Claudia Volpi
@en
Claudia Volpi
@es
Claudia Volpi
@nl
prefLabel
Claudia Volpi
@ast
Claudia Volpi
@en
Claudia Volpi
@es
Claudia Volpi
@nl
P106
P1153
9338160500
P21
P31
P496
0000-0002-3967-7954